Patent · US Active

Inhibitors of ribonucleotide reductase subunit 2 and uses thereof

US7427605B2 · kind B2 · utility

149Cited by

5References

14Claims

0Family size

Assignee

CALANDO PHARMACEUTICALS, INC. · US

Inventors

Mark E. Davis · Pasadena, US
Jeremy Heidel · Madison, US
John J. Rossi · Goleta, US

Key dates

Filing date	Mar 31, 2006
Grant date	Sep 23, 2008
Priority date	—
Expiry date	Jun 7, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to inhibitors of ribonucleotide reductase subunit 2 (R2), and methods and compositions related to the R2 inhibitors. In certain embodiments, the R2 inhibitors include nucleic acids, such as for example siRNAs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.